Letter: Tacrolimus May Be Hazardous in Decompensated Autoimmune Liver Disease With Hyperbilirubinemia-Authors’ Reply

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14651
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Tacrolimus May Be Hazardous in Decompensated Autoimmune Liver Disease With Hyperbilirubinaemia

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Autoimmune Hepatitis-Drug-Induced Liver Injury Must Always Be Excluded. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Acute Liver Failure of Indeterminate Aetiology-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: The Efficacy of Oltipraz in Patients With Non-Alcoholic Fatty Liver Disease Has Not Been Confirmed-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Vitamin D Deficiency and Autoimmune Hepatitis - From Research to Treatment-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Editorial: Liver Transplantation in Patients With Non-Alcoholic Fatty Liver Disease and Obesity-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: The Relationship Between Diet, Mood and Mucosal Healing in Coeliac Disease Remains to Be Verified-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy